Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 9
2019 18
2020 34
2021 28
2022 17
2023 13
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Type I interferon and cancer.
Holicek P, Guilbaud E, Klapp V, Truxova I, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Immunol Rev. 2024 Jan;321(1):115-127. doi: 10.1111/imr.13272. Epub 2023 Sep 4. Immunol Rev. 2024. PMID: 37667466 Review.
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W, Mead H, Tian L, Park JG, Garcia JI, Jaramillo S, Barr T, Kollath DS, Coyne VK, Stone NE, Jones A, Zhang J, Li A, Wang LS, Milanes-Yearsley M, Torrelles JB, Martinez-Sobrido L, Keim PS, Barker BM, Caligiuri MA, Yu J. Dong W, et al. J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20. J Virol. 2022. PMID: 34668775 Free PMC article.
Time to blur the blast boundaries.
DiNardo CD, Garcia-Manero G, Kantarjian HM. DiNardo CD, et al. Cancer. 2022 Apr 15;128(8):1568-1570. doi: 10.1002/cncr.34119. Epub 2022 Feb 8. Cancer. 2022. PMID: 35133004 Free article. No abstract available.
State-of-Art of Cellular Therapy for Acute Leukemia.
Lee JB, Vasic D, Kang H, Fang KK, Zhang L. Lee JB, et al. Int J Mol Sci. 2021 Apr 27;22(9):4590. doi: 10.3390/ijms22094590. Int J Mol Sci. 2021. PMID: 33925571 Free PMC article. Review.
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.
Garfall AL, Cohen AD, Susanibar-Adaniya SP, Hwang WT, Vogl DT, Waxman AJ, Lacey SF, Gonzalez VE, Fraietta JA, Gupta M, Kulikovskaya I, Tian L, Chen F, Koterba N, Bartoszek RL, Patchin M, Xu R, Plesa G, Siegel DL, Brennan A, Nelson AM, Ferthio R, Cosey A, Shea KM, Leskowitz R, Four M, Wilson WV, Miao F, Lancaster E, Carreno BM, Linette GP, Hexner EO, Young RM, Bu D, Mansfield KG, Brogdon JL, June CH, Milone MC, Stadtmauer EA. Garfall AL, et al. Blood Cancer Discov. 2023 Mar 1;4(2):118-133. doi: 10.1158/2643-3230.BCD-22-0074. Blood Cancer Discov. 2023. PMID: 36413381 Free PMC article.
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura F, Boyle EM, Coffey D, Maclachlan K, Gagler D, Diamond B, Ghamlouch H, Blaney P, Ziccheddu B, Cirrincione A, Chojnacka M, Wang Y, Siegel A, Hoffman JE, Kazandjian D, Hassoun H, Guzman E, Mailankody S, Shah UA, Tan C, Hultcrantz M, Scordo M, Shah GL, Landau H, Chung DJ, Giralt S, Zhang Y, Arbini A, Gao Q, Roshal M, Dogan A, Lesokhin AM, Davies FE, Usmani SZ, Korde N, Morgan GJ, Landgren O. Maura F, et al. Nat Cancer. 2023 Dec;4(12):1660-1674. doi: 10.1038/s43018-023-00657-1. Epub 2023 Nov 9. Nat Cancer. 2023. PMID: 37945755
CD73 Promotes Chronic Lymphocytic Leukemia.
Allard D, Chrobak P, Bareche Y, Allard B, Tessier P, Bergeron MA, Johnson NA, Stagg J. Allard D, et al. Cancers (Basel). 2022 Jun 26;14(13):3130. doi: 10.3390/cancers14133130. Cancers (Basel). 2022. PMID: 35804900 Free PMC article.
On point in primary CNS lymphoma.
Tsang M, Cleveland J, Rubenstein JL. Tsang M, et al. Hematol Oncol. 2020 Dec;38(5):640-647. doi: 10.1002/hon.2761. Epub 2020 Jul 3. Hematol Oncol. 2020. PMID: 32510610 Free PMC article. Review.
114 results